ARMS2/HTRA1 and CFH polymorphisms are not associated with choroidal neovascularization in highly myopic eyes of the elderly Japanese population

Eye

Volumn 24, Issue 6, 2010, Pages 1078-1084

  Nakanishi, H ^a   Gotoh, N ^a   Yamada, R ^a,b   Yamashiro, K ^a   Otani, A ^a   Hayashi, H ^a   Tsujikawa, A ^a   Shimada, N ^c   Ohno Matsui, K ^c   Mochizuki, M ^c   Saito, M ^d   Saito, K ^d   Iida, T ^d   Matsuda, F ^a,e   Yoshimura, N ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

Age related macular degeneration; Case?control association study; Choroidal neovascularization; Clinical genetics; Myopia; Single nucleotide polymorphism

Indexed keywords

COMPLEMENT FACTOR H; SERINE PROTEINASE OMI;

ADULT; AGED; APHAKIA; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MYOPIA; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUBRETINAL NEOVASCULARIZATION;

EID: 77953556387     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.215     Document Type: Article

References (49)

1. Soubrane G. Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment. Surv Ophthalmol 2008; 53: 121-138.
2. Ohno-Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 2003; 87: 570-573.
3. Grossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol 2004; 137: 496-503.
4. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996; 103: 1241-1244.
5. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 2006; 51: 316-363.
6. Gorin MB. A clinician's view of the molecular genetics of age-related maculopathy. Arch Ophthalmol 2007; 125: 21-29.
7. Swaroop A, Branham KE, Chen W, Abecasis G. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet 2007; 16(Spec No. 2): R174-R182.
8. Edwards AO, Ritter 3rd R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and agerelated macular degeneration. Science 2005; 308: 421-424.
9. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227-7232.
10. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419-421.
11. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
12. Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, Ott J et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005; 77: 149-153.
13. Baird PN, Islam FM, Richardson AJ, Cain M, Hunt N, Guymer R. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci 2006; 47: 4194-4198.
14. Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L et al. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006; 15: 3206-3218.
15. Lau LI, Chen SJ, Cheng CY, Yen MY, Lee FL, Lin MW et al. Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci 2006; 47: 3242-3246.
16. Magnusson KP, Duan S, Sigurdsson H, Petursson H, Yang Z, Zhao Y et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006; 3: e5.
17. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38: 1055-1059.
18. Postel EA, Agarwal A, Caldwell J, Gallins P, Toth C, Schmidt S et al. Complement factor H increases risk for atrophic age-related macular degeneration. Ophthalmology 2006; 113: 1504-1507.
19. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007; 297: 1793-1800.
20. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77: 389-407.
21. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger Tet al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14: 3227-3236.
22. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314: 989-992.
23. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ et al. A variant of the HTRA1 gene increases susceptibility to agerelated macular degeneration. Science 2006; 314: 992-993.
24. Cameron DJ, Yang Z, Gibbs D, Chen H, Kaminoh Y, Jorgensen A et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 2007; 6: 1122-1125. (Pubitemid 46708586)
25. Fisher SA, Rivera A, Fritsche LG, Babadjanova G, Petrov S, Weber BH. Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate. Br J Ophthalmol 2007; 91: 576-578.
26. Kanda A, Chen W, Othman M, Branham KE, Brooks M, Khanna R et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 2007; 104: 16227-16232.
27. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 2007; 144: 608-612.
28. Leveziel N, Souied EH, Richard F, Barbu V, Zourdani A, Morineau G et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis 2007; 13: 2153-2159.
29. Lu F, Hu J, Zhao P, Lin Y, Yang Y, Liu X et al. HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population. Vision Res 2007; 47: 3120-3123.
30. Mori K, Horie-Inoue K, Kohda M, Kawasaki I, Gehlbach PL, Awata T et al. Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population. J Hum Genet 2007; 52: 636-641.
31. Ross RJ, Bojanowski CM, Wang JJ, Chew EY, Rochtchina E, Ferris 3rd FL et al. The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci 2007; 48: 1128-1132.
32. Tanimoto S, Tamura H, Ue T, Yamane K, Maruyama H, Kawakami H et al. A polymorphism of LOC387715 gene is associated with age-related macular degeneration in the Japanese population. Neurosci Lett 2007; 414: 71-74.
33. Yoshida T, DeWan A, Zhang H, Sakamoto R, Okamoto H, Minami M et al. HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 2007; 13: 545-548.
34. Fernandez-Robredo P, Maestre SR, Zarranz-Ventura J, Mulero HH, Salinas-Alaman A, Garcia-Layana A. Myopic choroidal neovascularization genetics. Ophthalmology 2008; 115: 1632, 1632 e1.
35. Gushima H. Pharma SNP Consortium (PSC). Research on Pharmacokinetics related Genetic Polymorphism among Japanese Population. Xenobiotic Metab and Dispos 2001; 16: 340-345.
36. Pesarin F. Multivariate Permutation Tests: With Applications in Biostatistics. Wiley-Blackwell: Chichester, UK, 2001.
37. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
38. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-374.
39. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001; 132: 668-681.
40. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 486-495.
41. Curtin BJ, Karlin DB. Axial length measurements and fundus changes of the myopic eye. I. The posterior fundus. Trans Am Ophthalmol Soc 1970; 68: 312-334.
42. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992; 110: 1701-1708.
43. Sandberg MA, Tolentino MJ, Miller S, Berson EL, Gaudio AR. Hyperopia and neovascularization in age-related macular degeneration. Ophthalmology 1993; 100: 1009-1013.
44. Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 1998; 82: 996-1002.
45. Wang JJ, Mitchell P, Smith W. Refractive error and agerelated maculopathy: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 1998; 39: 2167-2171. (Pubitemid 28455088)
46. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000; 107: 2224-2232.
47. Ikram MK, van Leeuwen R, Vingerling JR, Hofman A, de Jong PT. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2003; 44: 3778-3782.
48. Xu L, Li Y, Zheng Y, Jonas JB. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol 2006; 90: 1087-1090. (Pubitemid 44351133)
49. Xu L, Li Y, Wang S, Wang Y, Wang Y, Jonas JB. Characteristics of highly myopic eyes: the Beijing Eye Study. Ophthalmology 2007; 114: 121-126.